Data & Analytics

NYU Langone and tech firm Tempus are launching a new protocol using serial DNA sequencing and AI to create hyper-personalized cancer treatments.

Eason Technology is betting its future on Chinese real estate with a deal that could dilute shareholders by over 80%. But can it get past the NYSE?

A new partnership makes Eli Lilly's powerful AI models available to smaller firms via Revvity's platform, aiming to accelerate innovation with federated learning.

Radiant Ridge Energy's new 40MW project in Alberta bypasses the grid, converting natural gas directly into power for the booming AI and data industry.

With a new CEO from Illumina and Exact Sciences, Quanterix signals a strategic shift from tech development to aggressive market and clinical expansion.

Record AI mega-deals redefine healthcare innovation, yet a broader market contraction creates a new divide for startups and traditional medical sectors.

One Washington Financial and Papilio Collective are launching a new model to embed expert support into fintechs, aiming to close the innovation gap for credit unions.

The investment giant's new podcast season tackles the energy trilemma, exploring AI's power thirst, the return of nuclear, and fossil fuel's role.

With pivotal data for its sickle cell drug and a new myelofibrosis program, Cellarity's AI-driven 'Cell State-Correcting' platform faces a crucial test.

A new partnership brings revolutionary 3D genome mapping from the lab to the clinic, offering new hope for patients with hard-to-treat cancers.

CEO Werner Lanthaler will present FairJourney Bio's data-driven antibody discovery platform at the elite J.P. Morgan conference, signaling major growth.

A newly validated genetic test accurately predicts melanoma risk, offering a non-invasive alternative to the standard surgical biopsy for many patients.

South Korean gim specialist Daingt is leveraging proprietary data and a 20-year legacy to innovate its seaweed, aiming to dominate the booming global market.

The global asset manager appoints Kikuo Shirose to lead its Japan office, signaling a deep push into the nation's booming real assets and alternatives market.

A new alliance pairs Relation's 'Lab-in-the-Loop' AI with Deerfield's investment might, aiming to fast-track novel drugs for intractable diseases.

With star hires and proprietary data analytics, Abacus Global Management is making an ambitious play for the booming asset-based finance sector.

LifeVantage heads to the ICR Conference to woo investors. Can its cellular health science overcome market headwinds and a volatile direct selling landscape?

Winning Data Platform of the Year, Authenticom’s DXM connects live operations with customer sentiment, aiming to fix problems before they happen.

Marvell's acquisition of XConn Technologies expands its CXL and PCIe switching portfolio, a strategic move to own the critical interconnect layer for AI.

A new partnership between Second Front Systems and Paramify leverages automation to slash software compliance times from years to months for government agencies.